New topical hair loss treatment shows a 539% improvement in trials, offering hope for male-pattern baldness sufferers after ...

Male pattern baldness, also known as androgenic alopecia, is a widespread form of hair loss that affects men, often beginning ...

New 2025 study results show Clascoterone, originally approved for acne, could be the first new effective topical for male ...

In two large late-stage clinical trials, the company’s experimental drug clascoterone triggered significant hair regrowth in ...

Male pattern baldness, also called androgenic alopecia, is the most common type of hair loss in men. It usually begins with ...

A new topical treatment, Clascoterone, shows significant promise for male pattern baldness, offering a novel approach beyond ...

A common acne medicine may soon change the future of hair loss treatment. New research shows clascoterone could become the ...

New research indicates that early or severe male pattern baldness in men with untreated high blood pressure is linked to hidden heart and blood vessel ...

Cosmo Pharmaceuticals says its Phase 3 trials of topical clascoterone for male-pattern hair loss showed statistically ...

A common acne medication may soon offer hope to millions of men struggling with hair loss. Ireland-based pharmaceuticals ...

It may be years before anyone can declare that an everyday acne lotion doubles as a baldness remedy. Still, a recent ...

In a trial, clascoterone showed a whopping 539 percent relative improvement in hair count compared to the placebo.